Does a normal TMAO level rule out digestive disorders?

TMAO is sometimes discussed as a microbiome-related biomarker, but its clinical meaning is narrow. For a 64-year-old woman with gastrointestinal symptoms, a circulating result reported as normal should not alter standard diagnostic evaluation.

Clinical interpretation

• A normal TMAO concentration does not exclude digestive disease. TMAO has no validated gastrointestinal diagnostic threshold or demonstrated rule-out performance (for example, sensitivity, negative predictive value, or likelihood ratios) for IBD, IBS, coeliac disease, or other digestive disorders.
• Small case-control findings of lower plasma TMAO in IBD, including lower values in active versus inactive ulcerative colitis, are exploratory. The same activity association was not established in Crohn’s disease, and these observations do not provide a clinically usable diagnostic cutoff.
• TMAO should not replace symptom- and risk-directed assessment. In suspected IBD versus IBS, established inflammatory markers such as fecal calprotectin and C-reactive protein are the relevant tests; chronic diarrhoea assessment may also include coeliac serology. Endoscopy or imaging depends on symptoms, examination, and alarm features.

Mechanistic interpretation

• Circulating TMAO integrates one diet–microbiome–host pathway: microbial conversion of choline, phosphatidylcholine, betaine, or carnitine to trimethylamine (TMA), followed by hepatic FMO3 oxidation of TMA to TMAO.
• Human isotope-tracer and antibiotic studies support a direct contribution of gut microbial metabolism to this pathway.
• Blood concentrations also reflect dietary intake, including preformed TMAO exposure, hepatic FMO3 activity, and renal elimination. TMAO is primarily cleared in urine, and reduced kidney function raises circulating values; meta-analytic evidence reports an inverse association with GFR.

Bottom line

• Normal TMAO is not a gastrointestinal rule-out test. It is best viewed as a nonspecific integrated signal of dietary exposure, microbial TMA generation, liver metabolism, and kidney clearance—not a validated assessment of global gastrointestinal function.